Inventor · disambiguated record
Sherin Salaheldin Abdel-Meguid
Also filed as: ABDEL-MEGUID SHERIN S · ABDEL-MEGUID SHERIN SALAHELDIN
11 granted patents·5 pending applications·185 citations·filing 1996–2020
90Inventor score
Files withSHIFA BIOMEDICAL CORP7SMITHKLINE BEECHAM CORP5DAIAMED INC1DENG HONGFENG1SMITHKLINE BEECHAM CORP AND SM1
Top patents by PatentIndex Score
16 records- 0191US7217794B2Compounds and methods for treatment of thrombosisDAIAMED INC·Filed 2004·Granted May 15, 2007·91 cites·6 claims
- 0290US10947220B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2020·Granted Mar 16, 2021·2 cites·7 claims
- 0390US10131637B2Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Nov 20, 2018·10 cites·6 claims
- 0489US6706487B1Monoclonal antibody and the method of using the antibodySMITHKLINE BEECHAM CORP·Filed 2000·Granted Mar 16, 2004·39 cites·8 claims
- 0585US9682085B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Jun 20, 2017·4 cites·5 claims
- 0678US10899748B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Granted Jan 26, 2021·2 cites·5 claims
- 0764US6274336B1Method of inhibiting cathepsin KSMITHKLINE BEECHAM CORP·Filed 1996·Granted Aug 14, 2001·28 cites·1 claims
- 0856US12274693B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation of compounds and methods of using the sameSHIFA BIOMEDICAL CORP·Filed 2019·Granted Apr 15, 2025·0 cites·30 claims
- 0955US2018079730A1Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Application pending·0 cites
- 1049US2004141964A1Recombinant IL-18 antagonists useful in treatment of IL-18 mediated disordersSMITHKLINE BEECHAM CORP AND SM·Filed 2004·Application pending·0 cites
- 1145US6245550B1Cytokine family member EF-7SMITHKLINE BEECHAM CORP·Filed 1998·Granted Jun 12, 2001·5 cites·3 claims
- 1244US2008146811A1Compounds and Methods For Treatment of ThrombosisDENG HONGFENG·Filed 2005·Application pending·0 cites
- 1342US2016256467A1Anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2016·Application pending·0 cites
- 1437US2001049121A1Cytokine family member, 2-19Filed 2001·Application pending·0 cites
- 1535US6008033AProteases, compositions capable of binding to said site, and methods of use thereofSMITHKLINE BEECHAM CORP·Filed 1998·Granted Dec 28, 1999·2 cites·26 claims
- 1634US6083711AProteases compositions capable of binding to said site, and methods of use thereofSMITHKLINE BEECHAM CORP·Filed 1997·Granted Jul 4, 2000·2 cites·66 claims
Join the waitlist — get patent alerts
Get an alert when Sherin Salaheldin Abdel-Meguid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →